• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From the Cochrane Library: Interventions for Chronic Pruritus of Unknown Origin.

作者信息

Parmar Pritika, Singal Amit, Szeto Mindy D, Pathak Gaurav N, Taranto Viktoria, Truong Thu M, Rao Babar, Miranda Andrea Andrade, Franco Juan Va, Dellavalle Robert P

机构信息

Department of Dermatology, University of Minnesota Medical School, Minneapolis, MN, United States.

Rutgers New Jersey Medical School, Newark, NJ, United States.

出版信息

JMIR Dermatol. 2024 Aug 21;7:e53271. doi: 10.2196/53271.

DOI:10.2196/53271
PMID:39167781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375376/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11375376/cf832315032c/derma_v7i1e53271_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11375376/cf832315032c/derma_v7i1e53271_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11375376/cf832315032c/derma_v7i1e53271_fig1.jpg

相似文献

1
From the Cochrane Library: Interventions for Chronic Pruritus of Unknown Origin.来自考克兰图书馆：不明原因慢性瘙痒的干预措施。
JMIR Dermatol. 2024 Aug 21;7:e53271. doi: 10.2196/53271.
2
Interventions for chronic pruritus of unknown origin.不明原因慢性瘙痒的干预措施。
Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD013128. doi: 10.1002/14651858.CD013128.pub2.
3
Treatment of patients with chronic pruritus of unknown origin with dupilumab.用度普利尤单抗治疗不明原因慢性瘙痒症患者。
J Dermatolog Treat. 2022 May;33(3):1754-1757. doi: 10.1080/09546634.2021.1880542. Epub 2021 Feb 8.
4
Efficacy of pregabalin for the treatment of chronic pruritus of unknown origin, assessed based on electric current perception threshold.基于电流感知阈值评估普瑞巴林治疗不明原因慢性瘙痒的疗效。
Sci Rep. 2020 Jan 23;10(1):1022. doi: 10.1038/s41598-020-57629-z.
5
Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin: A Nonrandomized Controlled Trial.阿布昔替尼治疗结节性痒疹和不明原因慢性瘙痒的疗效与安全性：一项非随机对照试验
JAMA Dermatol. 2024 Jul 1;160(7):717-724. doi: 10.1001/jamadermatol.2024.1464.
6
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.在一项 2 期、随机、安慰剂对照试验中，塞洛哌丁降低了结节性痒疹患者的瘙痒。
J Am Acad Dermatol. 2019 May;80(5):1395-1402. doi: 10.1016/j.jaad.2019.01.052. Epub 2019 Mar 17.
7
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.赛洛哌丁胺治疗慢性瘙痒症的随机、多中心、安慰剂对照 2 期临床试验结果。
J Am Acad Dermatol. 2018 May;78(5):882-891.e10. doi: 10.1016/j.jaad.2018.02.030. Epub 2018 Feb 17.
8
The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.NK1 受体拮抗剂塞洛哌丁胺治疗慢性瘙痒。
Expert Opin Investig Drugs. 2019 Aug;28(8):659-666. doi: 10.1080/13543784.2019.1638910. Epub 2019 Jul 4.
9
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial.塞洛匹坦治疗银屑病瘙痒：一项2期随机、双盲、安慰剂对照临床试验。
J Am Acad Dermatol. 2020 Jun;82(6):1314-1320. doi: 10.1016/j.jaad.2020.01.056. Epub 2020 Jan 30.
10
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial.神经激肽-1 受体拮抗剂治疗大疱性表皮松解症患者慢性瘙痒的 2 期临床试验：一项随机临床试验。
J Am Acad Dermatol. 2020 Jun;82(6):1415-1421. doi: 10.1016/j.jaad.2019.09.014. Epub 2019 Sep 18.

本文引用的文献

1
Treatment of patients with chronic pruritus of unknown origin with dupilumab.用度普利尤单抗治疗不明原因慢性瘙痒症患者。
J Dermatolog Treat. 2022 May;33(3):1754-1757. doi: 10.1080/09546634.2021.1880542. Epub 2021 Feb 8.
2
Itch in the era of COVID-19 pandemic: An unfolding scenario.新冠疫情时期的瘙痒：一个正在展开的情况。
Dermatol Ther. 2020 Sep;33(5):e13477. doi: 10.1111/dth.13477. Epub 2020 May 27.
3
Interventions for chronic pruritus of unknown origin.不明原因慢性瘙痒的干预措施。
Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD013128. doi: 10.1002/14651858.CD013128.pub2.
4
Efficacy of pregabalin for the treatment of chronic pruritus of unknown origin, assessed based on electric current perception threshold.基于电流感知阈值评估普瑞巴林治疗不明原因慢性瘙痒的疗效。
Sci Rep. 2020 Jan 23;10(1):1022. doi: 10.1038/s41598-020-57629-z.
5
Causes, pathophysiology, and treatment of pruritus in the mature patient.成年患者瘙痒的病因、病理生理学及治疗
Clin Dermatol. 2018 Mar-Apr;36(2):140-151. doi: 10.1016/j.clindermatol.2017.10.005. Epub 2017 Oct 17.
6
GRADE guidelines 6. Rating the quality of evidence--imprecision.GRADE 指南 6. 评估证据质量——不精确。
J Clin Epidemiol. 2011 Dec;64(12):1283-93. doi: 10.1016/j.jclinepi.2011.01.012. Epub 2011 Aug 11.